D-0729-2026 Class II Ongoing

Recalled by Fresenius Kabi USA, LLC — Lake Zurich, IL

FDA drug recall D-0729-2026 was initiated by Fresenius Kabi USA, LLC on Jul 16, 2026 and is designated Class II. Reason for recall: Presence of Particulate Matter: Hair was found in products The recall status is ongoing. Affected quantity: 37,250 vials.

Recall details

Product Type
Drugs
Report Date
Jul 29, 2026
Initiation Date
Jul 16, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
37,250 vials

Product description

Xylocaine (lidocaine HCl Injection, USP), 1%, 500 mg per 50 mL (10 mg per mL), 25 Multiple-Dose Vials, 50 mL, Rx only, Sterile, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-485-57; NDC Vial: 63323-485-03

Reason for recall

Presence of Particulate Matter: Hair was found in products

Distribution pattern

Nationwide within in the USA

Code information

Lot #: 6133986, Exp. Date 02/2029

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0729-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0729-2026. Report a data issue: hello@regdatalab.com.